Cargando…
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Uveal melanoma is considered a rare disease but it is the most common intraocular malignancy in adults. Local treatments are effective, but the systemic recurrence rate is unacceptably high. Moreover, once metastasis have developed the prognosis is poor, with a 5-year survival rate of less than 5%,...
Autores principales: | Castet, Florian, Garcia-Mulero, Sandra, Sanz-Pamplona, Rebeca, Cuellar, Andres, Casanovas, Oriol, Caminal, Josep Maria, Piulats, Josep Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627065/ https://www.ncbi.nlm.nih.gov/pubmed/31212986 http://dx.doi.org/10.3390/cancers11060834 |
Ejemplares similares
-
Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression
por: García-Mulero, Sandra, et al.
Publicado: (2021) -
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
por: Slater, Kayleigh, et al.
Publicado: (2020) -
Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma
por: Lorenzo, Daniel, et al.
Publicado: (2018) -
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor
por: Sundaramurthi, Husvinee, et al.
Publicado: (2022) -
Lung metastases share common immune features regardless of primary tumor origin
por: García-Mulero, Sandra, et al.
Publicado: (2020)